Vertex Pharmaceuticals | 225.5500 / -0.25% |
News
- Kymera Therapeutics Announces Key 2021 Goals and Milestones to Support its Evolution into a Fully Integrated Degrader Medicines Company
01/12/2021 / 13:00 - GlobeNewswire - Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer
12/17/2020 / 14:00 - GlobeNewswire - Sarepta Therapeutics Announces Executive Management Changes
12/14/2020 / 14:30 - GlobeNewswire - CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
12/14/2020 / 14:00 - GlobeNewswire - Spero Therapeutics Announces First Patient Dosed with SPR720 in Phase 2a Clinical Trial in Patients with Nontuberculous Mycobacterial Pulmonary Disease
12/10/2020 / 14:00 - GlobeNewswire - Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
12/09/2020 / 14:02 - GlobeNewswire - CRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication in the New England Journal of Medicine
12/05/2020 / 18:30 - GlobeNewswire - CRISPR Therapeutics and Vertex to Host Investor Webcast to Review Data Presented at the 62nd American Society of Hematology Annual (ASH) Meeting and Exposition for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ in Sickle Cell Disease and Beta Thalassemia
12/01/2020 / 15:00 - GlobeNewswire - Adicet Announces Appointment of Dr. Bastiano Sanna to its Board of Directors
12/01/2020 / 13:00 - GlobeNewswire - CRISPR Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
11/24/2020 / 14:00 - GlobeNewswire - Cytokinetics Names Nancy Wysenski to Board of Directors
11/20/2020 / 13:30 - GlobeNewswire - Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory
11/17/2020 / 13:00 - GlobeNewswire - Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020
11/16/2020 / 22:05 - GlobeNewswire - Foghorn Therapeutics Appoints Michael LaCascia as Chief Legal Officer
11/12/2020 / 15:00 - GlobeNewswire - Kymera Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
11/05/2020 / 13:00 - GlobeNewswire